Adherence to PARP inhibitor therapy among women with ovarian cancer. Moss HA, Chen L, Hershman DL, Davidson B, et al. Gynecol Oncol 2021 Sep 9. pii: S0090-8258(21)01323.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Moss HA, Chen L, Hershman DL, Davidson B, et al. Adherence to PARP inhibitor therapy among women with ovarian cancer. Gynecol Oncol 2021 Sep 9. pii: S0090-8258(21)01323.
PMID: 34509297